- Home
- VCEL vs PACS Comparison
VCEL vs PACS Comparison
Compare VCEL & PACS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VCEL
- PACS
- Stock Information
- Founded
- VCEL 1989
- PACS 2013
- Country
- VCEL United States
- PACS United States
- Employees
- VCEL N/A
- PACS N/A
- Industry
- VCEL Biotechnology: Biological Products (No Diagnostic Substances)
- PACS
- Sector
- VCEL Health Care
- PACS
- Exchange
- VCEL Nasdaq
- PACS Nasdaq
- Market Cap
- VCEL 2.1B
- PACS 2.0B
- IPO Year
- VCEL 1997
- PACS 2024
- Fundamental
- Price
- VCEL $34.05
- PACS $11.19
- Analyst Decision
- VCEL Strong Buy
- PACS Strong Buy
- Analyst Count
- VCEL 6
- PACS 6
- Target Price
- VCEL $61.50
- PACS $33.33
- AVG Volume (30 Days)
- VCEL 565.9K
- PACS 389.3K
- Earning Date
- VCEL 07-31-2025
- PACS 09-16-2025
- Dividend Yield
- VCEL N/A
- PACS N/A
- EPS Growth
- VCEL 2045.40
- PACS 82.80
- EPS
- VCEL 0.13
- PACS 0.68
- Revenue
- VCEL $249,119,000.00
- PACS $3,558,953,000.00
- Revenue This Year
- VCEL $18.35
- PACS $28.62
- Revenue Next Year
- VCEL $22.47
- PACS $16.94
- P/E Ratio
- VCEL $256.98
- PACS $16.21
- Revenue Growth
- VCEL 16.13
- PACS 205.08
- 52 Week Low
- VCEL $33.09
- PACS $8.28
- 52 Week High
- VCEL $63.00
- PACS $43.92
- Technical
- Relative Strength Index (RSI)
- VCEL 40.14
- PACS 43.62
- Support Level
- VCEL $33.34
- PACS $10.88
- Resistance Level
- VCEL $36.81
- PACS $12.02
- Average True Range (ATR)
- VCEL 1.36
- PACS 0.46
- MACD
- VCEL -0.13
- PACS -0.05
- Stochastic Oscillator
- VCEL 20.14
- PACS 20.79
About VCEL Vericel Corporation
Vericel Corp is a fully integrated, commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.
About PACS PACS Group Inc. Common Stock
PACS Group Inc is a post-acute healthcare company primarily focused on delivering high-quality skilled nursing care through a portfolio of independently operated facilities Its is a nursing providers in the United States based on number of facilities, with over 200 post-acute care facilities across nine states serving over 20,000 patients daily. It also provide senior care, assisted living, and independent living options in some of communities.